Common antiretroviral drug improves cognition in mouse model of Down syndrome

Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a new study. Though clinical studies are necessary to confirm that the drug elicits a similar effect in humans, the findings pave the way for pharmacological treatments that rescue the relatively rapid cognitive decline in people with Down syndrome that is more commonly seen in much older adults in the general population.

from Healthy Aging News -- ScienceDaily https://ift.tt/BJytsvx